When asked by Fortune what research supported the temporary usage of GLP-1s, Noom, Calibrate, and Embla all shared the same data points and one anothers internal research
Orforglipron, made by the same company that produces the GLP-1 medications Zepbound and Mounjaro (tirzepatide), is an oral medication undergoing FDA clinical tests for use in weight loss
marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]
The same is true for any peptide or hormone-based therapy
While not commonly reported with Pendulum specifically, people sensitive to gut-brain interactions may notice temporary mood fluctuations during the adjustment period
Example Impacts: Fitness Industry: The impact on the fitness industry is expected to change with time